Published in Obesity and Diabetes Week, February 17th, 2003
The peptide was discovered jointly by Dr. A.J. van der Lely, of the Erasmus Medical Center of Rotterdam in the Netherlands, and Dr. Ezio Ghigo, with University of Turin in Italy. The research and assignment agreement was signed with the discoverers and their affiliated institutions.
The company has filed an international patent application for the compound and thus will hold full rights to its intellectual property.
"Our objective is to build a strong and focused...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.